These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1032 related items for PubMed ID: 15223612

  • 1. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A, Ustün H, Ustundag Y, Aydemir S, Bayraktaroglu T, Sert M, Yilmaz A.
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-8 in chronic renal failure and dialysis patients.
    Nakanishi I, Moutabarrik A, Okada N, Kitamura E, Hayashi A, Syouji T, Namiki M, Ishibashi M, Zaid D, Tsubakihara Y.
    Nephrol Dial Transplant; 1994 Jun; 9(10):1435-42. PubMed ID: 7816257
    [Abstract] [Full Text] [Related]

  • 3. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F.
    Ren Fail; 2007 Jun; 29(2):147-54. PubMed ID: 17365928
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein.
    Kir HM, Eraldemir C, Dervisoglu E, Caglayan C, Kalender B.
    Clin Lab; 2012 Jun; 58(5-6):495-500. PubMed ID: 22783580
    [Abstract] [Full Text] [Related]

  • 5. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
    Borazan A, Aydemir S, Sert M, Yilmaz A.
    Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053
    [Abstract] [Full Text] [Related]

  • 6. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
    Liang M, Wang L, Hou FF, Liu J, Liu ZQ, Tian JW.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
    [Abstract] [Full Text] [Related]

  • 7. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y, Ebinç FA, Ebinç H, Paşaoğlu H, Demirtaş C, Taçoy G, Koç E, Derici U, Reis KA, Bali M, Arinsoy T, Sindel S.
    Ren Fail; 2008 Aug; 30(6):617-23. PubMed ID: 18661412
    [Abstract] [Full Text] [Related]

  • 8. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
    Goldstein SL, Leung JC, Silverstein DM.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
    [Abstract] [Full Text] [Related]

  • 9. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D, Colić M, Stanković-Popović V, Radojević M, Bokonjić D.
    Med Pregl; 2007 Sep; 60 Suppl 2():53-7. PubMed ID: 18928158
    [Abstract] [Full Text] [Related]

  • 10. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D, Vasilijic S, Colic M, Stankovic-Popovic V, Bokonjic D.
    Adv Perit Dial; 2009 Sep; 25():50-5. PubMed ID: 19886317
    [Abstract] [Full Text] [Related]

  • 11. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC, Baan CC, Hesse CJ, Loonen EH, Niesters HG, Zietse R, Weimar W.
    Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
    [Abstract] [Full Text] [Related]

  • 12. C-reactive-protein and cytokine plasma levels in hemodialysis patients.
    Boenisch O, Ehmke KD, Heddergott A, Naoum C, Frei U, Schindler R.
    J Nephrol; 2002 Feb; 15(5):547-51. PubMed ID: 12455722
    [Abstract] [Full Text] [Related]

  • 13. Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients?
    Seyrek N, Karayaylali I, Balal M, Paydas S, Aikimbaev K, Cetiner S, Seydaoglu G.
    Scand J Urol Nephrol; 2005 Feb; 39(5):405-9. PubMed ID: 16257843
    [Abstract] [Full Text] [Related]

  • 14. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
    Sebeková K, Podracká L, Heidland A, Schinzel R.
    Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
    [Abstract] [Full Text] [Related]

  • 15. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis.
    Rysz J, Banach M, Cialkowska-Rysz A, Stolarek R, Barylski M, Drozdz J, Okonski P.
    Cell Mol Immunol; 2006 Apr; 3(2):151-4. PubMed ID: 16696903
    [Abstract] [Full Text] [Related]

  • 16. Significance of elevated gingival crevicular fluid tumor necrosis factor-alpha and interleukin-8 levels in chronic hemodialysis patients with periodontal disease.
    Dağ A, Firat ET, Kadiroğlu AK, Kale E, Yilmaz ME.
    J Periodontal Res; 2010 Aug; 45(4):445-50. PubMed ID: 20337890
    [Abstract] [Full Text] [Related]

  • 17. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V, Taccola D, Rizza GM, Consani C, Migliori M, Filippi C, Paoletti S, Sidoti A, Borracelli D, Panicucci E, Giovannini L.
    J Nephrol; 2004 Aug; 17(5):715-20. PubMed ID: 15593040
    [Abstract] [Full Text] [Related]

  • 18. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M.
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [Abstract] [Full Text] [Related]

  • 19. Protein oxidative stress and dyslipidemia in dialysis patients.
    Marques de Mattos A, Marino LV, Ovidio PP, Jordão AA, Almeida CC, Chiarello PG.
    Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
    [Abstract] [Full Text] [Related]

  • 20. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M, Erbağci AB, Usalan C, Deveci R, Kocabaş R.
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 52.